Headline of the Day

The U.S. Food and Drug Administration (FDA), which has come under fire for seemingly rubber stamping Emergency Use Authorization (EUA) for COVID-19 testing without offering virtually any data-driven or appropriate testing standards, has been delivering EUAs to China-based pharmaceutical companies at an alarming rate.

After reviewing the 161 emergency use authorizations granted by the FDA since February, I found that at least 10 Chinese companies were delivered the FDA stamp of approval to deliver diagnostic tests in the United States for SARS-CoV-2, which causes COVID-19.

(Excerpt) Read more at: